Navigation Links
Hope For Patient With Alzheimer’s Diseas

New research shows combining the drugs memantine and donepezil may improve memory in patients with Alzheimer’s disease. //

Researchers studied more than 300 patients with moderate to severe Alzheimer’s. Participants were already taking the drug donepezil when the study began. Donepezil works by preventing the breakdown of acetylcholine, a chemical messenger in the brain that is important for memory and other thinking skills.For the study, patients received either memantine or a placebo. Memantine targets glutamate, a brain chemical that is associated with nerve cell death when produced in high quantities. The Food and Drug Administration approved memantine in October 2003.

Researchers found patients who took memantine and donepezil experienced significant improvement in cognition, memory, and overall daily functioning compared to those in the placebo group. Researchers say they were pleasantly surprised to see that the two drugs worked well together. Memantine is significant, since it provides an entirely new medication option for the 2.5 million people currently suffering at the advanced stage of Alzheimer’s.

Prior to the FDA’s approval of memantine, only acetylcholinesterase inhibitors, like donepezil, were approved for treating Alzheimer’s patients. Researchers say the study is significant because this is the first time combining two Alzheimer’s drugs has shown positive results.

Researchers conclude saying , “ To find a new medication that can provide substantial benefit to patients at this stage of the disease, either alone or in combination with another Alzheimer’s drug, is certainly good news ... While memantine is not a cure for Alzheimer’s, if it helps to keep a person with Alzheimer’s at home for six months or one year longer, then it is a victoy.”
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/30/2016)... ... April 30, 2016 , ... Orlando-based Maximized Living has selected Dr. ... gold in Rio. Under the care of Maximized Living doctors at the London ... unprecedented showing, Maximized Living is sending the largest contingent of elite chiropractors to Rio ...
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial Healthcare System Graduate ... Education (ACGME) that it has received accreditation for its residency program on Physical ... programs that Memorial is currently pursuing, including Pediatrics and Internal Medicine. This accreditation ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related ... 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a plethora ...
(Date:4/29/2016)... ... April 29, 2016 , ... Spine Team Texas, a comprehensive spine physician ... one of their physicians has been invited to be a featured speaker at the ... Review conference on April 30, 2016. , Dr. R. Scott McPherson, a physical ...
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 2016 Tie-up with Government hospitals ... to save newborns   Fortis La Femme, ... in collaboration with Breast Milk Foundation (BMF), a non-profit organization ... Milk Bank, ,Amaara, in Delhi-NCR today. This non-profit centre recognizes ... infants and should be available to babies deprived of mother,s ...
(Date:4/27/2016)... 2016 Oasmia Pharmaceutical AB ... a new generation of drugs within human and ... for Paclical/Apealea in the Phase III study that ... ovarian cancer. These preliminary results showed non-inferiority between ... carboplatin versus Taxol in combination with carboplatin. In ...
(Date:4/26/2016)... FLINT, Mich. , April 26, 2016 ... the promotion of Jennifer Hagerman , Pharm D., ... In her growing role at Diplomat, Hagerman will continue ... of the company that delivers custom education and training ... to the specialty pharmacy industry. Diplomat University also houses ...
Breaking Medicine Technology: